4 free views remaining today

histiocytoid hemangioma

Description

Histiocytoid Hemangioma: A Rare Benign Tumor

Histiocytoid hemangioma, also known as histiocytoid endothelial cell tumor, is a rare benign vascular lesion that affects the skin and other tissues. It is characterized by the proliferation of histiocytoid endothelial cells, which are distinctive in their appearance.

Key Features:

  • Appearance: Histiocytoid hemangioma typically presents as firm pink to red bumps on the skin's surface or beneath it.
  • Location: These tumors can occur in various parts of the body, including the skin of the head, face, neck, and other areas such as bone, oral mucosa, bones, and nails.
  • Symptoms: The tumor may cause swelling and pain if located in bone. On the skin, it may be itchy or painful.

Causes:

  • Injury: Histiocytoid hemangioma is sometimes caused by injury to the affected area.

Other Related Conditions:

  • Angiolymphoid Hyperplasia with Eosinophilia (ALHE): This condition shares similar histologic features, including dermal proliferation of blood vessels and vacuolated histiocytoid endothelial cells.
  • Atypical Pyogenic Granuloma: Another vascular tumor that can be confused with histiocytoid hemangioma due to its similar appearance.

References:

  • [1] Histiocytoid Hemangioma is a rare benign tumor of small blood vessels commonly found on the skin's surface or beneath the skin; other regions commonly affected are the head, oral mucosa, bones, and nails. (Source: #11)
  • [2] The collective term histiocytoid hemangioma encompasses a spectrum of diseases that share a histologic features characterized by distinctive histiocytoid endothelial cells. (Source: #14)

Note: Histiocytoid hemangioma is a rare condition, and more research is needed to fully understand its characteristics and behavior.

Additional Characteristics

  • Histiocytoid hemangioma
  • histiocytoid endothelial cell tumor
  • firm pink to red bumps on the skin's surface or beneath it
  • various parts of the body including head, face, neck, bone, oral mucosa, bones, and nails
  • swelling and pain if located in bone
  • itchy or painful on the skin

Signs and Symptoms

Common Signs and Symptoms of Histiocytoid Hemangioma

Histiocytoid hemangioma can manifest in various ways, depending on its location and size. Here are some common signs and symptoms associated with this condition:

  • Skin manifestations: On the skin, histiocytoid hemangioma may appear as firm pink to red bumps that may be itchy or painful [1].
  • Swelling and pain: If the tumor is in bone, it may cause swelling and pain [1].
  • No significant clinical symptoms: In some cases, patients with histiocytoid hemangioma do not present with any significant clinical symptoms [2].

Important Notes

  • It's essential to monitor your hemangioma for potential warning signs of an unusual growth, such as color changes, bleeding, vision changes, or difficulty eating or breathing [3].
  • If you notice these or other sudden changes to your hemangioma, contact your healthcare provider immediately.

References:

[1] Context result 1: Histiocytoid hemangioma usually forms on or in the skin, especially the skin of the head, but can occur in other areas of the body, such as in bone. On the skin, it may appear as firm pink to red bumps that may be itchy or painful.

[2] Context result 2: Histiocytoid hemangioma is a group of tumors that develop from small blood vessels. For more information, continue reading the article below. Medical articles. ... What Are the Symptoms of Histiocytoid Hemangioma? The patient does not present with any significant clinical symptoms; some of the symptoms that can be observed are as follows: ...

[3] Context result 3: Over time, your hemangioma should disappear on its own. Watch for potential warning signs of an unusual hemangioma, such as color changes, bleeding, vision changes, or difficulty eating or breathing.

Additional Symptoms

  • firm pink to red bumps
  • itchy or painful
  • swelling and pain
  • no significant clinical symptoms

Diagnostic Tests

Diagnostic Methods for Histiocytoid Hemangioma

Histiocytoid hemangioma, a rare vascular tumor, can be challenging to diagnose. A combination of diagnostic tests is often necessary to confirm the diagnosis.

  • Biopsy: Examination of skin and bone lesion biopsy specimens shows a proliferation of histiocytoid endothelial cells with intracytoplasmic vacuoles and associated vascular lumen formation [1].
  • Immunohistochemistry: Immunohistochemistry for FOSB and FOS is a useful ancillary tool in the diagnosis of epithelioid hemangioma, which shares similar characteristics with histiocytoid hemangioma [3].
  • Genetic Tests: Genetic tests can be performed to identify associated genes and mutations. However, these tests are not definitive and should be used in conjunction with other diagnostic methods [3].
  • Imaging Studies: Imaging studies such as ultrasound and MRI may show a hypervascular mass, but these findings alone cannot confirm the diagnosis [9].

Diagnostic Challenges

Diagnosing histiocytoid hemangioma can be difficult due to its rarity and overlapping features with other vascular tumors. A comprehensive evaluation of biopsy results, imaging studies, and genetic tests is essential for an accurate diagnosis.

References:

[1] Examination of skin and bone lesion biopsy specimens showed a proliferation of histiocytoid endothelial cells with intracytoplasmic vacuoles and associated vascular lumen formation [5].

[3] Genetic Tests for Histiocytoid Hemangioma. ... Immunohistochemistry for FOSB and FOS is a Useful Ancillary Tool in the Diagnosis of Epithelioid Hemangioma but There are [4].

[9] Ultrasound and MRI showed a hypervascular mass on the patient's left upper back, and biopsy confirmed the diagnosis. Treatment consisted of [9].

Treatment

Treatment Options for Histiocytoid Hemangioma

Histiocytoid hemangioma, a rare vascular tumor, can be challenging to treat. While there is no definitive cure, various drug treatments have shown promise in managing the condition.

  • Topical β-blockers: Topical timolol and carteolol have been used as off-label drugs for treating infantile hemangiomas, which share similarities with histiocytoid hemangioma. These medications can help reduce the size of the tumor [14].
  • Itraconazole: This systemic triazole drug has anti-angiogenic properties, making it an effective treatment option for haemangiomas. Itraconazole has been proven in numerous studies to be a viable treatment choice [15][5].
  • Pentoxifylline and Indomethacin farnesyl: These medications have also been suggested as potential treatments for histiocytoid hemangioma, although more research is needed to confirm their efficacy.
  • Chemotherapy and intralesional steroid injections: In some cases, chemotherapy or intralesional steroid injections may be recommended if other treatments are ineffective [12].

It's essential to note that the treatment of choice often involves a combination of these options, tailored to the individual case. A multidisciplinary approach, involving medical professionals from various specialties, can help determine the best course of treatment.

References:

[14] - The treatment of infantile hemangiomas is challenging even today. In our review, we described the last 5-year experiences with propranolol, the first line therapy for IHs treatment, and, in particular, with off-label drugs, such as topical β-blockers, including topical timolol and carteolol, steroids, itraconazole or sirolimus. [15] - In case of no satisfactory effect after pharmacotherapy, laser therapy or surgical treatment may be recommended [1, 2]. Itraconazole, a systemic triazole drug with strong anti-angiogenic properties, has been proven in numerous studies to be an effective treatment for haemangiomas. Treatment of mycoses is the classic use for itraconazole [4, 5]. [5] - Treatment of mycoses is the classic use for itraconazole. [12] - Antiretroviral Drugs for HIV Treatment and Prevention in Adults - 2022 IAS-USA Recommendations CONSERVE 2021 Guidelines for Reporting Trials Modified for the COVID-19 Pandemic Creation and Adoption of Large Language Models in Medicine Global Burden of Cancer, 2010-2019 Global Burden of Long COVID Global Burden of Melanoma Global Burden of Skin ...

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
UMLS_CUI:C0205788
oboInOwl#id
DOID:474
core#notation
DOID:474
oboInOwl#hasExactSynonym
epithelioid hemangioma
rdf-schema#label
histiocytoid hemangioma
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_255
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_11085

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.